rfhg_121395.1

Basic information about the TSS

---

TSS ID: rfhg_121395.1 Species: human Chr: chr9		Start: 136849786 End: 136849805 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4252909,EH38E2737245)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000463215.1:-7 GeneID: 29085 HGNC/MGI_ID: HGNC:30033 UniProt_ID: Nearer transcript ids and distances: LF346345:224 MA581922:224 LF346346:-286 MA581923:-286 AF393504:-355 CR533481:-355 AB528207:-356 AM393672:-356 KJ898712:-356 ENST00000497413.1:-360 ENST00000462205.5:-361 AF164795:-363 AL136644:-376 BC024648:-376 AF161490:-376 ENST00000247665.12:-377 NM_014172.6:-377 NM_001135861.3:-377 NM_001287343.2:-377 NM_001287342.2:-377 NR_109808.2:-377 NR_109807.2:-377 view more...

Gene_name: phosphohistidine phosphatase 1 Gene_symbol: PHPT1 Gene_synonyms: CGI-202 DKFZp564M173 HSPC141 PHP14 bA216L13.10 Gene_source: HGNC:30033

TATA-Box annotation

---

Distance to TSS:	979
Nearest PromoterID:	NM_001287343
Entrez ID:	29085
Nearest Unigene:	Hs.409834
Nearest Refseq:	NM_014172
Nearest Ensembl:	ENSG00000054148
Gene Name:	phosphohistidine phosphatase 1
Gene Alias:	CGI-202|HEL-S-132P|HSPC141|PHP|PHP14
Gene Type:	protein-coding
CpG%:	0.105263
GC%:	0.700000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PHPT1 p2@PHPT1 p5@PHPT1 p6@PHPT1 p7@PHPT1 p8@PHPT1 p10@PHPT1
Sample		p1@PHPT1	p2@PHPT1	p5@PHPT1	p6@PHPT1	p7@PHPT1	p8@PHPT1	p10@PHPT1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.40	1.17	0.00	1.17	0.97	0.39	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.89	0.40	0.40	0.81	2.02	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	27.97	1.35	0.39	1.35	1.35	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	20.79	0.83	0.21	1.66	1.46	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.25	1.12	0.22	0.67	2.92	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	21.71	1.74	0.58	0.39	0.78	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.16	0.22	0.65	0.65	1.31	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.77	0.00	0.97	0.73	0.97	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.86	1.50	0.21	0.85	0.85	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	0.58	0.58	2.32	1.74	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.51	0.81	0.81	1.62	1.62	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	2.85	1.22	0.41	1.22	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	53.52	4.51	5.80	0.32	1.29	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	58.64	4.36	7.07	1.05	1.35	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	46.11	3.51	6.37	0.66	1.10	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	46.02	7.04	7.54	1.01	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	36.47	4.59	4.80	0.87	0.87	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.85	3.37	6.75	0.84	1.27	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.66	2.67	11.73	0.53	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	66.34	2.56	8.12	0.30	1.05	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	57.60	5.88	6.01	0.53	0.94	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	59.04	5.01	7.42	0.35	1.73	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.92	4.78	5.17	0.90	0.90	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	44.41	5.34	5.82	0.24	0.97	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	41.54	2.84	6.97	1.03	0.77	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	47.48	3.48	9.18	0.32	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.82	1.65	7.69	0.55	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	64.12	4.24	6.13	0.24	1.41	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	62.67	2.91	8.88	0.97	0.48	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	59.36	3.26	7.06	0.36	1.09	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	49.61	4.19	6.70	0.00	1.26	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	48.26	5.08	7.42	0.20	0.78	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	59.09	5.91	8.65	0.21	0.84	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	57.56	3.30	6.10	1.32	1.65	1.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	57.41	2.99	7.85	0.19	1.50	0.37	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	52.12	3.07	6.71	0.57	1.15	0.38	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	65.61	3.47	5.31	0.82	1.23	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	52.99	5.04	6.25	0.20	1.61	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	56.99	3.78	6.75	0.81	0.81	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	54.97	3.12	5.04	0.00	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	55.52	3.29	7.76	0.00	1.18	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	48.90	1.76	6.73	0.29	0.73	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	51.25	2.74	6.54	0.63	1.48	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	54.02	2.97	6.82	0.70	0.70	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	63.24	3.41	4.42	0.40	0.60	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	59.79	4.89	6.98	1.16	1.40	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	47.50	4.56	6.24	0.24	0.48	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	59.31	5.36	5.07	0.89	2.09	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	48.35	4.55	5.98	0.24	1.20	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	57.02	4.85	9.50	0.81	0.61	1.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	34.43	4.30	5.53	0.20	0.61	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	44.70	4.45	4.45	0.22	0.44	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	39.03	4.26	3.90	0.00	2.13	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	41.42	4.97	7.62	0.33	1.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	25.17	1.68	0.84	0.84	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	44.09	1.84	3.67	1.38	1.38	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	39.54	5.19	9.08	0.32	0.97	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.19	6.74	5.78	0.00	1.28	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	50.61	2.51	2.51	1.57	1.26	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	32.43	2.82	3.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	41.50	2.80	6.17	2.24	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	34.23	7.17	3.18	0.80	1.59	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	34.66	4.76	5.10	0.00	1.36	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	37.69	4.55	4.22	0.32	0.97	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	35.14	3.19	3.90	1.06	0.71	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	37.05	7.31	4.39	0.00	1.46	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.76	2.98	4.46	0.50	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	4.22	5.16	0.94	0.47	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.21	4.97	4.64	0.66	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.75	6.19	7.73	0.31	0.31	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.33	7.34	7.64	0.00	1.22	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	33.58	2.06	0.32	2.22	0.63	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	28.07	1.60	1.12	1.12	0.80	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	33.59	3.18	0.00	2.54	0.38	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	67.27	5.23	0.00	0.75	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	61.96	4.02	0.00	0.33	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	67.63	1.28	0.00	1.91	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	41.78	3.30	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	17.61	1.35	2.26	1.35	1.81	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	44.49	3.65	0.87	1.56	1.22	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	39.70	2.54	1.96	1.56	0.39	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	15.19	1.03	1.54	0.26	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	27.04	2.51	1.39	1.12	0.84	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	4.70	1.18	2.35	1.76	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	48.02	4.18	1.13	0.72	1.21	1.05	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	27.43	3.55	2.26	0.32	0.65	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	22.39	2.67	1.07	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	17.81	2.23	1.11	1.11	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	52.40	1.66	1.66	0.42	2.50	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	27.63	2.51	1.76	1.00	0.75	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	36.32	2.29	0.33	0.65	0.65	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	24.66	1.52	0.91	0.30	1.22	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	41.33	2.87	1.55	0.66	1.10	0.44	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	109.37	5.38	15.42	0.72	2.15	1.79	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	45.52	4.79	3.59	1.20	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	44.62	1.08	1.08	0.36	2.34	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	73.63	3.35	0.00	0.00	3.35	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	50.33	2.05	1.44	0.00	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	33.98	6.52	2.52	1.03	1.49	1.14	0.23
Anulus Pulposus Cell, donor2	11463-119B5	64.90	8.08	3.18	0.49	1.22	0.73	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	57.51	4.04	3.15	0.45	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	71.20	2.60	0.43	1.30	1.74	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	53.51	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	64.27	4.78	0.60	0.00	1.49	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	70.82	1.26	1.26	1.26	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	42.90	4.62	4.62	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	58.80	2.60	0.97	0.65	1.62	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	74.27	3.88	4.85	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	28.51	2.97	0.59	1.19	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	65.53	3.39	0.75	1.51	1.88	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	71.12	4.35	1.45	0.00	1.45	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	31.34	2.51	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	41.51	2.97	2.31	0.66	0.82	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	90.08	2.73	0.00	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	51.12	4.07	1.51	0.30	1.81	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	73.94	2.68	3.21	1.07	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	81.05	3.78	0.76	0.38	1.13	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	33.95	2.41	1.07	0.80	1.07	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	75.11	4.88	0.98	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	80.44	2.99	1.49	0.33	1.33	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	6.00	3.60	3.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	63.98	3.26	1.03	1.03	0.69	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	69.42	3.88	1.94	0.97	2.91	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	88.79	3.79	0.38	1.90	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	54.51	3.63	2.42	0.00	3.63	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	82.08	3.42	0.57	0.00	1.14	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	71.61	5.34	1.71	0.86	1.07	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	40.26	3.36	1.81	1.03	0.52	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	69.44	3.75	3.75	1.41	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	68.49	1.93	2.25	0.00	1.93	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	50.66	2.85	2.14	2.14	2.85	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	63.76	4.09	1.75	0.00	1.17	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	55.10	3.01	1.20	1.20	1.51	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	57.02	7.13	3.56	1.19	3.56	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	82.39	3.56	1.53	1.02	2.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	73.10	6.37	2.29	1.02	1.27	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	48.92	2.54	3.18	1.27	1.27	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	60.41	3.88	2.16	0.43	1.73	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	75.36	1.91	1.06	0.85	2.75	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	41.18	3.48	2.61	0.58	1.16	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	67.08	3.78	3.78	1.89	3.78	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	67.30	2.37	0.85	0.85	1.36	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	4.63	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	78.17	2.11	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	62.61	3.86	1.72	0.64	1.50	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	37.30	5.41	1.80	1.20	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	76.54	2.92	1.46	1.46	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	76.32	2.53	1.61	0.69	1.84	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	2.55	5.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	48.81	4.32	1.78	0.25	1.27	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	72.87	3.30	1.03	1.03	1.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	43.76	3.06	1.53	0.61	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	77.44	3.35	0.96	0.00	2.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	64.53	2.88	2.00	0.44	1.33	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	1.53	0.00	3.05	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	69.24	2.77	2.22	1.11	2.77	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	68.58	2.65	0.53	1.06	1.59	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	34.16	2.54	1.82	0.73	1.82	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	49.50	6.02	2.09	0.00	1.35	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	87.46	4.45	2.05	0.51	2.57	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	49.92	8.18	1.47	1.26	1.68	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	53.33	7.67	2.09	0.35	1.05	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	43.52	5.50	2.91	1.78	1.13	0.65	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	48.33	5.07	2.39	0.89	1.19	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	31.54	0.34	0.00	1.26	0.46	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.69	0.25	0.13	0.50	0.88	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	24.92	0.23	0.00	0.57	0.68	0.00	0.00
Basophils, donor1	12241-129G9	12.29	0.00	0.00	0.26	0.26	0.00	0.00
Basophils, donor2	12242-129H1	11.91	0.00	0.00	0.36	0.72	0.00	0.00
Basophils, donor3	12243-129H2	18.23	0.00	0.15	0.44	0.29	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	38.16	3.02	0.86	1.51	1.94	1.51	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	116.58	12.34	9.14	0.00	5.03	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	7.17	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	59.63	2.51	3.77	0.00	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	61.76	1.04	2.08	0.83	2.29	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	43.06	3.68	1.84	0.46	2.53	1.15	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	44.45	3.60	1.80	1.08	1.62	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	33.70	0.21	0.10	0.31	1.75	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	62.65	0.93	0.23	4.89	2.10	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	44.77	0.00	0.32	0.64	2.56	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	15.78	0.56	0.00	0.00	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	5.57	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	10.10	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.60	0.85	0.00	0.85	0.28	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.61	1.14	0.00	0.76	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	14.79	0.66	0.00	0.00	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	5.20	0.00	0.00	0.14	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	2.72	0.00	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	7.58	0.00	0.00	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.69	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.69	0.00	0.00	0.00	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.21	0.25	0.00	0.00	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.70	0.00	0.00	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.52	0.00	0.00	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	8.92	0.00	0.00	0.00	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.79	0.23	0.23	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.58	0.00	0.00	0.00	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	0.00	0.00	0.00	0.15	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.19	0.20	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.79	0.42	0.00	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.03	0.00	0.00	0.00	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.62	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.49	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.65	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	7.50	0.00	0.00	0.17	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.73	0.42	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.78	0.00	0.00	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.01	0.00	0.00	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	0.37	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.25	0.22	0.00	0.00	0.43	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.91	1.23	1.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.25	0.23	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.02	0.23	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	17.87	0.22	0.00	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	12.70	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	21.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	13.86	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	10.65	0.17	0.17	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	10.26	0.00	0.00	0.00	0.45	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	21.18	0.00	0.00	0.00	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	9.44	0.00	0.00	0.00	0.44	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	18.74	0.00	0.00	0.00	0.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	20.34	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	13.86	0.00	0.00	0.00	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	17.69	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.95	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	21.18	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	0.00	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	5.75	0.00	0.00	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.98	0.73	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	5.55	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	20.61	0.81	7.68	0.40	0.81	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	26.77	0.40	5.19	0.00	1.60	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	12.05	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	11.24	0.00	0.00	0.00	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	40.96	0.00	0.38	0.75	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	44.42	0.00	0.23	0.45	1.13	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	3.93	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	11.63	0.00	0.61	0.61	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	7.93	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	36.75	0.00	0.00	0.00	0.77	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	30.32	0.00	0.00	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	37.08	0.57	0.00	0.00	1.72	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.11	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11.94	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	21.10	0.29	0.14	0.29	0.43	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.08	0.34	0.17	0.17	0.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	36.11	0.81	0.16	0.16	0.64	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.97	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.53	0.00	0.00	0.00	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	9.68	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	19.82	0.84	0.84	0.42	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	36.78	1.04	0.21	0.42	0.62	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	33.08	0.67	0.33	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	5.71	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	8.58	0.54	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	0.00	0.00	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	28.00	0.00	0.00	0.00	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.34	0.22	0.00	0.22	0.65	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.90	0.00	0.00	0.63	0.84	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.70	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.86	0.00	0.00	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	11.77	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.17	0.49	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	20.31	0.00	0.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	30.71	0.00	0.00	0.00	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	23.54	0.28	0.00	0.00	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	24.54	0.25	0.00	0.00	0.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	0.00	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	25.43	0.00	0.00	0.00	1.07	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	37.39	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	6.55	0.00	0.00	0.00	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	8.26	0.38	0.00	1.13	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	5.30	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.81	3.67	3.44	2.75	1.15	0.23	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.54	4.07	1.92	3.35	0.48	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.60	3.56	4.10	2.46	1.09	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	33.92	3.00	2.40	4.20	2.10	0.60	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.16	5.04	2.64	3.60	0.72	1.20	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	19.33	4.09	2.73	3.41	0.45	0.91	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.47	4.13	2.82	3.69	1.52	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.42	3.68	2.90	5.00	1.84	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.51	3.05	3.75	1.88	1.17	1.41	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.23	3.32	2.72	2.11	2.42	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.27	2.32	4.07	2.91	1.45	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	27.71	2.93	3.46	2.66	2.93	1.07	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	13.13	3.06	2.63	0.88	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.12	5.01	1.37	0.46	0.91	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	3.73	2.24	0.75	0.75	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.05	4.68	1.80	1.80	1.44	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.44	2.88	2.30	2.01	2.59	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	20.98	3.06	2.12	3.54	2.59	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.04	2.22	1.58	2.85	3.17	1.58	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	29.22	5.54	1.23	2.77	1.54	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.80	2.56	1.60	4.17	0.64	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.98	3.44	3.44	2.29	0.76	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	14.19	3.15	2.36	1.97	2.36	0.00	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	11.35	3.78	1.51	3.78	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.07	10.44	2.41	2.41	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.88	11.19	6.99	3.50	1.40	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	25.04	14.02	3.01	1.00	1.00	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	31.07	0.00	1.83	3.66	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	41.50	0.99	2.96	0.99	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	42.30	1.79	1.05	4.21	0.74	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	28.43	6.93	26.00	2.08	1.04	0.00	1.39
Chondrocyte - de diff, donor2	11338-117F6	32.69	4.26	6.04	1.42	1.42	1.07	0.36
Chondrocyte - de diff, donor3	11410-118E6	28.79	5.46	12.52	1.71	1.02	1.25	0.46
Chondrocyte - re diff, donor2	11339-117F7	39.39	6.27	2.69	0.00	0.90	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	30.33	5.26	3.64	2.83	1.21	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	43.95	3.21	0.34	0.46	1.95	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	54.72	4.28	0.86	1.28	2.57	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	49.82	2.39	0.44	1.06	1.24	0.09	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	29.89	4.03	1.01	0.92	0.83	0.55	0.00
Corneal Epithelial Cells, donor1	11526-119I5	47.21	2.20	1.76	1.10	1.98	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	36.40	1.14	3.41	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	40.13	1.53	0.77	1.02	2.56	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	18.16	0.33	0.50	0.33	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	24.60	0.00	0.00	0.95	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.75	0.32	0.32	1.40	0.32	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	20.50	0.68	0.00	0.34	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	43.09	0.00	0.00	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.13	0.48	0.00	0.48	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	48.53	0.83	0.50	0.50	1.33	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	76.87	0.59	0.59	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	47.79	2.26	0.28	0.57	0.85	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	42.07	1.18	0.00	0.79	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	67.77	2.33	0.29	0.29	1.16	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	34.35	1.65	0.47	0.00	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	53.64	1.40	0.70	0.88	0.70	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.66	1.99	0.89	2.44	1.11	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	52.64	0.61	0.61	0.61	0.91	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.65	0.85	1.13	1.13	0.85	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	82.60	3.86	2.38	0.89	2.38	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	90.07	6.25	1.04	0.00	3.12	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	72.45	3.54	1.42	0.28	1.84	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	48.81	1.60	0.80	0.80	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	71.28	2.62	1.57	0.00	1.57	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.35	0.62	0.12	0.25	0.99	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.94	0.00	0.22	0.43	0.43	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	38.35	0.61	0.24	0.61	1.10	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	78.49	2.28	0.00	0.00	4.55	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	44.70	0.00	0.00	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	58.41	0.94	0.16	0.31	1.88	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	38.36	4.89	0.98	1.47	0.73	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	4.16	6.24	0.00	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	26.68	6.16	2.87	2.05	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	31.20	4.16	1.42	1.86	0.77	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	38.35	5.74	4.33	1.84	1.52	1.08	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.99	3.27	1.46	2.18	1.21	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	26.88	3.55	0.41	3.00	0.00	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.38	4.96	1.48	2.32	0.84	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	27.67	0.53	1.32	4.48	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.57	4.65	3.32	0.66	0.66	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	68.04	4.54	2.72	0.91	1.81	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	32.59	6.06	1.52	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	80.91	6.31	2.68	3.00	1.89	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	28.19	1.82	1.21	0.61	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	36.17	1.65	0.76	1.27	0.89	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	36.69	1.36	1.06	0.45	0.76	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	45.29	3.08	1.47	1.61	0.13	0.54	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	30.20	3.02	1.29	4.31	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	51.27	1.46	0.00	4.39	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	36.90	6.23	2.31	0.92	1.61	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	16.45	4.24	3.56	1.53	0.51	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	32.63	0.23	0.94	0.70	1.41	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	32.55	0.94	0.00	0.00	1.89	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	24.54	1.33	2.06	0.97	1.21	0.48	0.00
Fibroblast - Dermal, donor4	11450-119A1	27.58	2.03	3.17	0.34	0.57	0.23	0.34
Fibroblast - Dermal, donor5	11454-119A5	21.98	1.22	3.14	0.35	1.22	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	32.81	0.97	3.74	0.49	0.81	0.16	0.32
Fibroblast - Gingival, donor1	11237-116D4	26.45	2.92	4.16	1.25	0.83	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.39	4.45	4.19	1.05	0.26	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	18.05	2.77	2.11	0.26	0.66	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	22.33	3.67	6.09	1.64	0.48	0.39	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	43.63	6.23	6.23	2.08	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.78	7.58	6.34	1.94	0.88	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	27.28	6.70	13.72	0.47	1.25	1.71	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.48	4.60	12.58	0.54	0.68	1.22	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	17.29	7.41	5.65	0.35	0.71	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.72	4.09	7.60	0.00	1.17	1.02	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.82	3.68	10.91	0.82	0.41	1.36	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.05	3.62	14.59	0.66	0.88	1.21	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	28.32	7.04	6.75	1.32	0.15	1.17	0.15
Fibroblast - Lung, donor1	11270-116H1	62.53	1.36	1.36	0.00	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	13.43	1.49	1.49	1.49	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	40.10	2.53	2.32	0.84	1.90	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	32.49	3.33	0.83	0.83	2.50	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	40.56	4.20	2.80	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	31.63	6.16	2.80	1.68	0.84	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	34.10	0.41	1.62	0.00	0.81	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	39.94	3.99	0.00	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	24.05	1.94	2.72	0.58	0.97	0.39	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.30	1.67	4.40	0.15	1.06	0.61	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.97	2.75	4.59	0.31	0.31	0.61	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.02	4.96	6.11	0.38	2.29	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	52.11	3.24	3.78	0.81	1.08	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.95	1.62	4.41	0.58	0.93	0.46	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	41.12	1.55	1.22	1.77	0.66	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	22.96	2.64	3.86	0.81	1.83	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	3.34	3.34	1.34	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	69.19	3.56	2.77	3.16	1.98	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	20.44	2.78	1.98	0.60	0.40	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	31.97	4.80	2.84	1.78	0.53	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	22.66	5.72	5.12	1.58	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.17	4.21	2.71	1.50	0.90	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	38.97	6.59	3.56	0.32	0.86	0.32	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.51	4.81	2.78	1.52	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	35.60	3.61	3.61	1.80	0.66	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	21.05	7.82	4.21	1.60	0.00	0.60	0.80
Fibroblast - skin normal, donor2	11561-120D4	35.36	4.32	6.13	1.51	1.21	0.60	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.81	5.44	1.81	0.91	0.00	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.46	5.05	3.65	1.49	0.50	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.87	4.62	3.42	1.88	0.51	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.08	4.93	3.94	0.66	0.66	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	47.40	5.86	5.97	0.43	1.92	0.85	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	34.58	4.05	3.04	0.51	0.34	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.36	2.35	3.29	1.57	0.63	1.25	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	14.82	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	43.69	1.91	1.39	0.17	1.91	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.71	4.16	1.82	0.52	0.26	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.75	1.02	0.77	0.26	0.77	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	30.62	2.30	4.59	3.06	1.53	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	16.59	1.91	5.10	3.19	5.10	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	57.91	0.86	2.28	1.71	2.85	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	96.24	9.38	12.41	3.03	2.21	2.76	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	69.41	9.36	7.99	5.48	1.37	1.83	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	50.52	2.97	3.76	2.77	2.77	0.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	81.94	6.08	13.48	4.23	2.64	1.32	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	99.15	15.66	11.42	7.18	2.94	0.98	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	43.34	3.10	3.10	2.65	2.21	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	36.32	2.54	2.54	3.82	1.41	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	36.82	5.42	5.30	4.43	0.99	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	35.73	3.76	1.34	4.30	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	29.49	4.71	3.47	1.12	0.25	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	30.87	2.49	3.32	1.52	0.83	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	26.43	2.44	2.03	2.24	0.61	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	44.04	7.30	6.16	4.34	0.91	2.28	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	32.76	4.24	5.36	2.74	1.49	0.75	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	27.76	5.68	6.34	4.15	1.75	1.31	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	48.46	7.68	5.02	2.95	1.48	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.04	2.07	2.38	2.54	0.64	0.64	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.56	3.13	5.14	4.92	1.34	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	36.29	2.82	1.81	2.02	1.01	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.13	1.87	1.87	2.21	1.02	0.85	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	29.00	4.17	4.08	4.17	0.35	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.99	3.54	1.77	1.77	0.21	0.42	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.40	3.93	1.71	2.05	0.17	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	35.19	3.43	1.88	2.10	0.66	0.11	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.54	2.66	2.83	3.58	0.25	0.83	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.04	3.27	0.82	2.65	0.61	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.91	3.09	1.65	3.09	0.00	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	32.97	3.00	0.46	2.19	0.69	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	40.86	2.17	1.33	2.33	0.67	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.03	4.63	0.66	2.87	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	36.41	2.58	0.86	2.58	0.74	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	38.90	2.43	3.40	4.38	1.30	0.49	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.92	6.74	0.96	5.45	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.69	3.03	1.23	2.18	0.57	0.66	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	35.59	3.80	0.95	2.85	0.16	0.47	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.94	3.34	1.82	2.13	0.91	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.36	4.29	0.52	2.09	0.84	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.72	4.39	1.32	3.29	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.44	2.81	1.12	3.37	0.28	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	20.18	2.50	0.93	1.11	0.83	0.56	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.02	2.94	1.07	1.60	0.27	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.61	2.14	1.07	1.53	0.46	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	28.89	2.59	1.81	1.04	0.39	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.97	4.88	0.54	2.17	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.53	2.21	0.00	3.50	0.55	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	35.97	2.19	0.22	3.51	0.00	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	29.75	2.98	0.99	0.00	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.17	3.03	0.53	2.37	0.13	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.68	4.64	0.61	2.22	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	14.74	6.35	0.25	1.78	0.00	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	47.18	2.19	1.59	4.38	1.19	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	39.29	1.39	1.54	5.24	1.54	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	34.57	0.41	0.82	5.11	2.25	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	50.69	3.13	7.20	1.56	0.94	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	51.43	1.70	5.09	1.98	1.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	37.82	4.61	3.23	4.15	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	0.00	4.95	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	52.22	2.71	4.25	1.55	2.32	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	62.57	6.42	0.00	3.21	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	38.25	0.00	10.43	0.00	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	45.24	2.60	2.60	2.60	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	51.06	2.88	4.94	5.77	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	0.00	3.33	3.33	0.00	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	51.46	2.52	6.15	3.08	1.68	1.12	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	43.47	4.25	4.90	4.25	2.29	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	2.52	5.03	2.52	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	45.80	3.18	5.41	2.86	1.27	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.72	2.38	5.77	1.36	0.34	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	91.88	4.18	6.26	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	65.29	2.29	2.86	2.29	1.72	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	62.16	3.85	5.92	2.96	1.18	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	72.85	1.69	8.47	3.39	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	59.65	2.90	4.56	5.38	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	60.98	5.75	4.83	3.68	1.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	100.10	15.81	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	49.97	3.08	5.00	2.69	1.92	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	67.48	8.15	2.28	5.54	0.65	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	77.59	10.03	10.03	3.34	1.34	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	67.81	7.71	5.01	1.93	0.39	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	50.32	10.27	7.53	5.82	0.34	1.37	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	74.54	2.48	7.45	9.94	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.66	7.55	4.72	3.30	1.42	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	68.80	7.24	6.03	0.60	3.62	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	70.71	7.12	9.66	4.07	1.53	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	74.18	6.38	4.79	3.99	0.80	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	83.38	8.39	4.44	3.95	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	72.01	10.62	4.72	3.54	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	74.10	7.00	5.83	4.08	2.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	69.78	4.83	2.63	3.07	0.88	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	70.36	5.93	3.39	5.93	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	80.58	6.57	3.58	6.57	1.79	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	86.86	6.79	4.85	4.37	1.94	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	81.03	5.71	2.28	0.00	2.28	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	44.08	6.65	3.74	0.42	0.83	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	32.61	7.87	10.12	1.12	3.37	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.01	4.76	2.85	4.76	1.90	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	59.74	8.77	2.92	4.60	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.28	24.72	44.68	1.86	2.20	9.98	6.03
Hep-2 cells mock treated, biol_rep2	11899-125E9	27.01	26.00	37.81	1.69	0.84	7.09	5.74
Hep-2 cells mock treated, biol_rep3	11900-125F1	25.25	17.75	30.03	1.37	1.37	9.10	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	35.31	27.76	44.27	1.75	1.53	10.49	7.32
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.72	25.14	37.18	4.51	1.29	8.60	6.02
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.51	19.81	31.65	1.72	1.29	7.32	4.52
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	37.11	23.04	43.59	2.62	2.24	9.09	5.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	23.33	18.53	30.36	2.74	1.72	9.61	4.63
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.40	18.26	34.60	1.92	0.96	8.97	5.45
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	69.95	2.24	1.68	0.56	2.24	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	40.25	2.60	2.16	1.73	2.60	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	43.74	3.17	0.00	1.06	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	53.04	6.54	5.09	2.18	1.45	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.62	2.27	0.87	1.40	1.22	0.52	0.35
Hepatocyte, donor1	11523-119I2	18.16	1.21	1.21	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	14.01	2.15	3.23	3.23	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	17.79	0.00	0.61	0.00	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.76	0.00	0.00	0.65	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.18	0.35	0.52	2.45	0.17	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	39.93	2.61	0.69	0.69	0.55	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	60.49	0.00	3.18	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	0.00	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	53.99	0.00	5.54	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	0.00	2.50	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	11.87	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	61.51	0.00	7.69	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	9.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	73.09	3.25	4.87	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	40.02	0.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	0.00	0.00	3.63	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	62.20	3.97	1.32	5.29	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	2.22	3.33	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	41.57	0.63	5.04	2.52	0.00	0.00	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	69.60	0.00	4.64	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	43.28	3.23	7.11	1.94	0.00	0.65	3.23
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	46.69	1.61	4.83	6.44	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	51.34	0.81	6.52	2.44	1.63	2.44	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	47.02	2.10	3.36	1.68	0.00	1.26	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	42.60	1.61	3.21	0.80	1.61	0.80	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	53.55	3.69	2.77	1.85	0.92	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	40.60	1.42	2.83	2.36	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	42.63	0.91	3.63	1.81	0.00	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	3.23	6.46	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	50.82	5.08	2.54	3.81	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.78	6.38	6.38	1.91	0.00	3.19	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	54.68	1.82	5.47	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	38.56	6.43	6.43	0.00	0.00	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	59.73	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	39.20	1.23	5.25	2.16	0.31	0.62	2.16
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	49.17	7.02	1.76	1.76	0.00	3.51	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	3.14	3.14	0.00	6.29	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	40.33	1.39	7.65	3.48	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	0.00	6.64	4.43	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	3.24	16.21	6.48	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	36.62	1.74	1.74	6.98	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	83.24	4.50	13.50	6.75	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	3.48	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	5.33	9.60	2.13	0.00	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	58.19	1.39	4.16	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	65.54	8.55	5.70	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	36.82	3.68	9.20	0.92	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	84.71	3.03	9.08	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	46.52	2.11	4.23	3.17	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	18.77	1.39	1.22	0.41	0.65	0.49	0.08
Keratinocyte - epidermal, donor2	11349-117G8	26.94	0.59	1.76	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	26.03	0.57	0.76	0.38	0.38	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	46.77	3.06	1.48	1.70	1.25	0.23	0.23
Keratocytes, donor1	11527-119I6	35.76	6.53	1.72	2.41	0.69	1.03	0.34
Keratocytes, donor2	11607-120I5	28.12	5.86	14.06	0.00	2.34	2.34	1.17
Keratocytes, donor3	11688-122I5	16.40	0.59	2.96	1.98	1.58	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	42.07	2.16	1.08	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	64.47	5.65	1.38	0.35	1.50	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	76.19	7.77	0.71	2.93	1.21	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	72.57	4.27	2.96	1.19	0.83	0.47	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	41.86	2.51	3.07	0.56	0.28	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	44.71	2.05	1.89	2.68	0.79	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	36.03	3.23	3.23	0.54	2.69	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	33.41	3.15	1.89	0.63	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	49.38	2.37	2.70	1.83	0.86	0.65	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.06	2.05	2.46	0.41	1.23	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	49.05	3.03	4.30	1.01	1.77	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	47.43	3.10	1.83	1.13	1.27	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	41.14	5.93	3.96	0.40	0.40	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	40.52	2.13	2.52	0.39	1.16	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	58.14	2.22	2.41	1.85	0.93	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	45.64	3.83	3.14	1.05	0.70	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.56	4.05	2.86	0.95	0.00	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	47.66	2.06	2.47	0.96	0.82	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	41.88	3.08	2.16	0.92	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	40.84	3.12	2.81	0.94	2.49	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.51	2.74	3.48	0.91	0.91	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	43.77	2.30	3.62	0.99	0.99	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	43.35	2.34	3.51	0.59	0.88	0.29	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	51.28	3.24	2.49	1.74	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	41.22	4.85	3.88	0.97	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	36.62	3.50	3.50	1.08	1.62	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	51.01	2.72	3.33	1.21	1.51	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	37.84	2.59	3.11	1.04	3.11	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	45.02	4.40	3.14	0.84	0.63	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	52.63	2.26	3.01	1.20	1.95	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	45.40	2.75	2.06	0.69	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	42.90	2.63	2.45	0.75	0.75	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	52.38	2.86	3.61	0.85	0.85	0.42	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	32.95	4.36	1.94	0.48	0.00	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	37.71	2.65	4.63	0.66	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	50.55	1.98	2.85	0.87	0.99	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	35.91	4.07	3.70	0.37	1.48	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	40.52	3.46	4.20	0.99	0.25	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	48.67	2.47	1.65	0.82	1.24	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	33.77	1.61	1.29	0.00	0.64	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	34.69	1.22	3.65	0.30	0.30	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	42.97	1.96	1.82	0.98	0.84	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	45.87	3.91	2.13	1.07	1.42	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	35.87	2.91	3.88	0.97	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	61.00	2.96	2.96	0.62	1.09	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	44.41	4.30	3.58	1.07	3.58	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	41.81	3.92	4.57	0.00	1.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	52.50	1.65	3.06	1.41	1.18	1.18	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	54.70	4.33	2.48	1.24	0.74	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	49.43	2.05	3.07	0.26	1.28	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	51.32	2.98	3.28	0.90	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	97.44	0.00	2.27	15.86	2.27	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	95.89	1.53	1.53	0.77	2.30	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	77.93	0.74	1.48	2.23	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	47.81	2.54	2.12	3.81	1.69	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	104.09	2.11	1.41	2.81	2.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	82.19	1.87	1.87	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	37.61	1.55	0.52	4.64	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	108.24	1.19	1.19	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	82.11	0.90	0.00	0.90	2.04	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	44.50	1.16	1.74	4.07	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	81.03	2.70	0.00	5.40	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	65.44	2.03	1.49	3.12	1.63	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	57.00	2.05	1.54	4.62	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	92.10	1.41	1.41	2.82	1.06	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	49.31	1.33	0.67	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	46.86	1.53	2.04	4.58	2.55	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	73.64	1.33	0.80	1.60	1.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	76.33	0.76	2.27	3.21	1.51	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	50.93	0.61	1.84	2.45	1.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	96.22	1.63	1.63	3.26	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	73.09	1.67	1.04	4.37	1.25	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	48.49	0.84	1.68	3.08	1.96	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	78.31	4.12	1.03	2.06	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	80.41	0.58	0.58	2.03	3.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	49.62	0.00	0.60	3.59	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	84.65	1.66	0.55	2.21	1.66	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	66.10	1.06	0.00	3.18	2.47	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	45.36	2.95	0.74	5.16	1.84	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	90.95	1.15	1.15	3.45	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	75.60	1.92	1.92	4.22	1.15	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	41.89	0.00	1.70	2.83	3.40	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	92.71	0.00	1.64	0.82	4.92	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	72.75	1.81	1.36	5.87	2.71	0.00	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	56.02	2.87	1.44	5.03	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	76.18	1.49	2.24	3.73	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	72.83	1.11	1.11	3.72	1.49	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	51.69	1.29	0.86	2.15	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	108.75	0.00	3.43	1.71	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	79.96	0.33	0.67	4.33	1.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	60.93	0.60	1.81	2.41	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	95.98	1.42	2.13	2.13	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	76.31	3.78	1.72	2.06	0.69	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	49.92	0.00	0.54	1.07	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	102.35	1.35	1.35	4.04	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	84.45	0.00	1.85	2.22	1.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	88.38	0.00	0.00	3.49	4.65	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	103.66	2.12	1.06	1.06	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	74.43	2.80	2.00	2.80	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	53.79	1.45	0.73	1.45	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	124.94	3.07	1.53	2.30	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	88.79	0.99	1.48	1.97	1.97	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	44.22	0.00	0.94	4.70	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	102.58	1.01	0.50	3.02	3.02	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	66.69	0.00	0.90	0.90	1.80	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	0.00	1.72	3.44	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	110.00	0.00	0.45	3.56	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	65.30	1.56	0.78	2.74	1.56	0.39	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	48.16	1.32	2.64	2.64	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	110.53	2.59	1.04	2.59	2.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	70.45	1.31	1.75	3.06	1.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	57.03	1.68	1.12	4.47	1.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	90.98	1.77	2.21	3.53	3.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	82.93	1.16	0.39	4.63	3.47	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	46.08	0.51	1.01	6.08	4.56	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	75.46	0.96	1.44	3.36	2.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	74.74	1.59	1.19	2.39	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	41.93	0.61	1.22	2.43	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	86.46	0.00	1.38	2.08	2.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	82.46	0.76	0.38	3.80	3.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	48.03	1.03	0.52	1.55	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	73.77	1.81	0.00	2.42	3.02	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	70.35	1.58	2.85	4.12	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	44.25	0.53	4.26	3.20	1.60	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	87.92	1.72	0.00	1.72	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	79.19	1.54	1.03	4.11	2.06	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.90	0.00	0.71	4.24	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	94.77	1.13	2.27	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	59.08	1.66	1.66	2.91	1.66	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	34.45	0.78	0.00	4.70	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	81.84	1.67	1.25	2.09	1.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	75.74	0.46	0.46	5.11	1.39	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	42.15	2.68	2.68	3.35	1.34	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	94.63	3.74	1.60	2.14	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	68.70	1.62	0.00	4.85	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	53.23	0.92	1.84	0.92	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	82.69	1.78	3.56	1.78	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	83.77	1.71	2.28	3.99	1.14	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	52.92	2.30	0.77	3.83	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	64.02	1.64	1.64	2.19	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	75.73	1.34	0.45	2.67	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	57.71	3.12	1.56	2.86	1.30	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	73.60	0.66	2.65	1.33	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	85.22	0.00	0.00	2.08	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	18.92	0.00	0.23	0.46	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	36.15	1.10	0.18	0.73	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	24.12	1.18	1.57	0.52	0.79	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	66.38	2.12	1.59	0.53	0.53	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	46.43	5.07	3.64	0.63	1.27	0.63	0.32
Mallassez-derived cells, donor3	11930-125I4	42.11	2.22	2.64	0.42	1.39	0.56	0.14
Mammary Epithelial Cell, donor1	11273-116H4	21.02	9.67	7.37	1.59	0.60	1.10	0.80
Mammary Epithelial Cell, donor2	11350-117G9	30.11	6.37	6.95	1.16	1.45	0.87	1.45
Mammary Epithelial Cell, donor3	11422-118F9	77.07	2.00	4.24	0.75	2.24	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	14.91	1.36	3.39	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	30.71	0.54	0.22	0.11	0.32	0.22	0.11
Mast cell, donor2	11565-120D8	26.75	1.49	0.00	1.78	0.30	0.00	0.00
Mast cell, donor3	11566-120D9	33.54	3.15	0.45	1.80	0.45	0.23	0.23
Mast cell, donor4	11567-120E1	40.24	2.84	0.53	1.77	0.71	0.53	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	13.64	0.78	0.11	0.11	0.55	0.11	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	8.17	0.00	0.58	0.00	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	24.44	1.38	0.46	0.34	1.15	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	13.72	0.17	0.33	0.33	0.84	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	57.61	1.39	0.60	0.50	0.40	0.30	0.00
Melanocyte - dark, donor2	11582-120F7	48.45	0.69	3.11	1.04	1.04	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	33.76	2.25	1.09	0.36	0.72	0.80	0.22
Melanocyte - light, donor1	11274-116H5	27.74	0.47	0.47	0.24	0.71	0.00	0.24
Melanocyte - light, donor2	11351-117H1	29.35	0.00	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	36.42	1.73	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	28.01	0.31	0.62	0.42	0.52	0.00	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	44.38	1.34	1.34	0.81	1.08	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	44.73	0.54	0.27	0.54	0.54	0.00	0.00
Meningeal Cells, donor1	11493-119E8	32.88	2.23	1.12	0.12	1.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	47.54	0.00	0.44	0.44	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	17.20	1.22	0.65	0.24	0.57	0.08	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	35.64	5.99	0.29	0.86	2.00	0.57	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.54	2.82	0.81	1.01	0.81	0.50	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	105.13	38.11	27.60	2.63	0.00	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	26.16	3.92	5.23	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.03	0.72	3.59	0.72	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.86	3.60	0.85	0.42	1.06	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.63	4.02	2.01	1.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	38.24	4.61	1.98	0.88	1.10	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	28.49	5.84	5.84	2.19	3.65	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	25.17	4.30	1.84	0.41	1.23	0.82	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	60.53	15.37	5.40	1.11	1.66	1.25	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	41.26	7.06	3.72	1.49	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.55	4.34	3.42	3.29	0.26	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.49	21.37	18.99	11.57	0.59	2.08	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	14.01	11.68	9.34	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	52.51	16.01	7.68	1.92	1.28	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.74	1.77	1.77	1.42	1.06	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.77	4.38	2.50	2.19	0.63	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	54.43	3.63	1.45	0.73	2.90	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	45.61	1.33	1.06	0.53	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	71.57	1.50	0.50	0.50	0.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	40.25	0.87	0.14	0.14	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.69	0.49	0.74	0.49	1.23	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.50	1.47	0.88	0.29	2.94	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.94	0.00	0.31	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.87	1.04	0.83	0.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	34.04	0.75	0.75	0.50	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.67	0.47	0.93	0.47	1.40	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.79	0.41	0.00	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	29.70	1.19	0.00	0.00	2.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	27.43	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	27.74	1.14	1.90	0.76	1.52	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	21.22	0.21	0.42	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	15.65	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.60	0.60	0.30	0.00	1.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	0.00	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.32	0.00	0.25	0.00	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.49	1.19	0.71	0.24	0.71	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.19	0.55	0.00	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.04	0.00	0.23	0.23	0.23	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	27.34	0.63	0.21	0.21	1.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	16.31	0.41	0.00	0.82	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.66	0.86	0.21	0.43	0.64	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	23.79	1.11	0.89	0.22	0.67	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.83	0.66	0.66	0.00	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.21	0.51	0.51	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.87	0.82	0.27	0.00	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.23	1.47	0.29	0.00	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	1.09	0.00	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.07	0.48	0.00	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	21.61	0.40	0.00	0.40	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	0.00	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	23.03	0.50	0.00	0.50	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.14	0.88	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.10	0.50	0.25	0.74	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	18.12	0.68	0.34	0.68	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.01	0.88	0.44	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.52	0.00	0.00	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.99	0.56	0.28	1.12	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.86	0.42	0.42	0.00	2.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	0.00	0.00	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.16	0.00	0.00	0.60	1.21	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	29.63	0.83	0.83	0.42	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	0.92	0.00	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	26.75	0.57	0.00	1.14	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.75	0.28	0.00	0.83	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.29	0.00	0.26	1.30	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.46	0.43	0.43	0.43	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	0.00	0.64	1.27	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.27	0.00	0.00	0.27	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	28.44	1.50	0.60	0.30	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.75	0.28	0.00	0.57	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.74	0.32	0.32	0.96	1.59	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	38.92	1.33	0.44	0.88	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.72	0.00	0.00	0.76	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.36	0.85	0.00	0.57	0.85	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	36.38	1.72	0.74	0.98	0.98	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	0.00	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.47	0.00	0.00	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	32.29	2.88	0.29	0.58	0.86	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.42	0.30	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.94	0.66	0.00	0.33	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	31.56	0.00	0.00	0.00	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.58	0.40	0.40	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	0.00	0.00	0.00	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.15	0.00	0.00	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.37	0.27	0.00	0.00	1.07	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.85	0.34	0.11	0.45	0.90	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	24.31	0.74	0.74	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.69	0.37	0.00	0.00	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.57	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	26.26	0.00	0.00	0.00	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	0.84	0.42	0.42	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	44.51	0.00	0.64	1.27	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	36.44	0.00	0.00	0.81	2.43	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	0.00	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	41.15	7.11	0.86	2.37	1.51	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.90	1.05	0.52	4.70	1.57	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	1.33	2.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	26.71	1.67	3.34	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	29.66	3.04	3.23	0.38	1.52	0.95	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	3.19	1.60	1.60	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	16.32	4.08	1.36	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	0.00	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.56	5.02	1.26	0.00	0.84	0.42	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	33.01	5.35	6.51	0.23	1.16	0.23	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.67	2.97	1.35	0.27	0.27	0.81	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.22	4.63	1.47	0.42	0.63	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	11.13	11.13	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	27.30	8.93	4.47	1.49	0.99	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	27.34	4.60	1.89	1.35	1.89	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	31.74	5.89	3.63	0.45	0.68	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.50	4.08	1.96	0.16	0.65	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	31.17	4.01	1.46	0.36	0.73	0.91	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.17	5.83	4.24	0.00	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.21	9.00	5.40	0.60	1.20	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	29.86	3.94	0.98	0.66	0.66	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	32.85	3.74	1.95	0.81	1.46	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	30.87	3.88	2.47	0.88	1.41	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	19.69	4.92	4.92	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	26.66	1.84	8.73	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	33.74	5.14	2.25	0.64	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	45.87	2.76	0.69	3.10	2.07	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	0.00	0.00	10.11	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	25.84	3.56	0.45	0.89	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.02	1.69	2.96	0.00	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	26.58	3.56	2.14	0.24	0.95	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	36.06	7.73	5.15	1.29	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	35.65	6.00	2.67	0.33	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.09	4.06	1.80	2.71	1.80	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.28	5.56	3.17	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	1.86	4.64	3.71	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	44.65	7.19	3.03	1.51	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	26.40	4.56	1.63	3.58	1.30	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.23	5.67	0.87	0.44	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	35.28	2.71	0.90	1.81	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	18.52	4.41	3.53	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.95	5.32	1.33	1.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	47.62	8.43	0.99	0.00	0.99	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	27.18	2.68	1.91	0.38	1.53	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.69	0.91	0.91	2.12	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.43	3.32	1.11	0.66	0.66	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	22.36	3.39	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	40.24	4.27	0.00	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.96	3.78	3.15	0.94	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.61	3.33	0.61	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	27.69	5.54	1.58	0.00	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	32.88	2.27	1.13	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00	5.06	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	22.24	3.60	2.61	1.99	0.75	0.99	0.62
Myoblast, donor2	11322-117D8	27.81	3.07	2.69	2.11	0.77	0.19	0.19
Myoblast, donor3	11398-118D3	35.82	4.04	4.04	0.50	1.35	0.67	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	22.62	0.44	0.15	0.29	0.58	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	10.15	0.62	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	6.33	0.00	0.00	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	6.63	0.00	0.00	0.00	0.18	0.18	0.00
Neural stem cells, donor1	11275-116H6	25.41	4.36	1.09	1.45	0.73	1.09	0.00
Neural stem cells, donor2	11352-117H2	36.59	1.93	0.00	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	68.27	0.00	0.00	2.28	1.14	0.00	0.00
Neurons, donor2	11574-120E8	58.12	4.40	0.44	0.66	0.44	0.00	0.00
Neurons, donor3	11655-122E8	52.62	4.11	0.00	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	18.29	9.50	4.39	1.90	0.47	0.71	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	46.56	11.72	3.91	1.30	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	60.77	4.41	2.41	1.00	0.40	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	19.13	2.48	2.89	2.34	0.00	0.41	0.14
Olfactory epithelial cells, donor2	11934-125I8	28.66	4.20	4.20	2.46	1.88	1.16	0.29
Olfactory epithelial cells, donor3	11935-125I9	23.50	4.09	2.84	2.50	0.23	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	25.23	7.99	3.80	2.34	0.19	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	37.31	1.20	1.81	1.20	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	34.88	4.89	1.49	4.47	0.85	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	83.45	4.57	1.14	3.43	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	54.00	1.86	2.48	1.86	3.72	0.00	0.00
Osteoblast, donor1	11277-116H8	111.01	8.60	0.78	1.95	3.71	0.20	0.39
Osteoblast, donor2	11354-117H4	16.15	6.32	0.70	2.11	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	69.31	8.35	1.60	2.13	1.24	0.71	0.18
Pancreatic stromal cells, donor1	11249-116E7	29.74	3.96	2.27	1.18	0.93	0.42	0.08
Pericytes, donor1	11491-119E6	73.77	12.02	1.89	1.11	2.00	0.67	0.00
Pericytes, donor2	11571-120E5	83.30	7.92	3.85	1.36	1.58	0.68	0.00
Pericytes, donor3	11652-122E5	37.43	7.73	4.88	2.03	1.42	0.61	0.41
Perineurial Cells, donor1	11499-119F5	44.19	2.26	1.70	2.15	0.23	0.00	0.00
Perineurial Cells, donor2	11579-120F4	42.60	0.83	1.20	0.46	0.55	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	5.10	0.00	0.00	0.32	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	8.08	0.00	0.00	0.00	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.41	0.00	0.00	0.13	0.26	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	99.01	1.43	3.11	2.63	1.91	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	128.63	1.11	3.33	1.11	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	106.80	1.37	1.96	3.73	1.37	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	36.08	4.43	0.95	1.90	1.27	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	24.20	2.81	0.19	1.13	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.93	2.22	0.26	2.22	0.26	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	47.51	3.60	1.80	1.80	0.45	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	23.44	2.13	0.32	2.34	0.53	0.32	0.00
Preadipocyte - omental, donor2	11329-117E6	39.28	5.24	0.00	3.06	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	42.54	2.15	0.86	2.58	1.15	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	88.58	1.97	0.98	1.97	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.81	5.53	1.23	2.15	1.54	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	28.51	4.07	3.19	1.24	0.53	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	52.62	3.75	1.53	2.38	1.02	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	21.33	5.31	3.17	1.21	1.21	0.56	0.19
Preadipocyte - visceral, donor2	11357-117H7	17.95	3.68	1.38	0.46	0.46	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	36.26	5.12	5.22	0.21	1.04	0.42	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	14.18	0.00	0.00	4.22	0.15	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	25.73	4.87	2.84	2.57	1.08	0.54	0.68
Prostate Epithelial Cells, donor3	11404-118D9	18.07	1.84	2.02	1.22	0.98	0.06	0.12
Prostate Stromal Cells, donor1	11254-116F3	26.88	2.51	2.62	3.76	1.14	0.68	0.34
Prostate Stromal Cells, donor2	11332-117E9	43.75	7.89	7.89	5.56	1.43	1.61	0.36
Prostate Stromal Cells, donor3	11405-118E1	44.21	8.65	5.11	2.50	1.04	1.25	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	39.42	4.01	1.82	1.46	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	29.32	2.08	0.83	0.97	0.69	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	48.19	2.54	2.03	0.51	1.01	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	46.24	2.13	2.85	0.71	2.13	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	25.20	2.96	0.42	0.74	0.53	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	73.53	2.04	0.68	0.00	2.72	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	55.39	1.08	1.48	0.27	1.62	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	44.40	3.11	1.33	0.89	1.33	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	37.93	3.33	2.00	2.00	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	48.20	5.06	2.20	0.44	1.32	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	31.98	1.25	1.88	2.51	2.51	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	53.26	5.27	2.50	1.39	1.11	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	31.67	1.07	3.22	2.15	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.88	1.27	0.84	0.84	2.95	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	38.18	1.54	1.93	0.58	1.74	0.58	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	57.04	4.67	4.67	0.52	2.59	0.78	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	25.87	0.85	0.00	1.14	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	1.03	1.03	1.03	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.55	0.50	0.75	3.01	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.11	2.00	2.14	1.07	0.00	0.40	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	7.15	10.72	0.89	0.00	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	3.85	4.40	11.01	1.10	0.00	1.10	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	7.54	4.64	11.02	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	23.01	1.69	1.04	0.00	1.04	0.65	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.95	2.88	2.09	0.20	1.69	0.60	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	24.76	3.68	2.45	0.78	1.45	0.89	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	27.17	0.87	0.50	0.25	0.99	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	26.81	3.03	2.91	0.23	1.86	0.82	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	19.65	5.55	4.85	0.92	1.16	0.92	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	34.36	1.37	1.10	0.00	1.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	22.24	3.03	2.87	0.45	0.91	0.61	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	33.69	3.23	3.23	0.36	1.25	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	33.28	3.30	2.01	0.14	1.58	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.29	3.22	3.00	0.32	1.61	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	28.10	3.76	3.54	0.44	1.33	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	30.59	1.72	1.15	0.19	1.72	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.80	2.42	1.49	0.28	2.42	0.47	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	17.85	4.89	3.95	0.19	1.50	0.75	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.12	1.86	0.93	0.13	2.12	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.29	1.95	1.95	0.10	1.27	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	21.58	2.86	3.82	0.19	1.34	0.57	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.32	1.39	1.28	0.11	1.28	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.26	3.64	1.12	0.28	1.12	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.27	3.59	2.91	0.00	0.51	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	28.99	1.46	2.55	0.00	0.91	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.05	2.45	2.21	0.25	1.72	0.74	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	30.09	2.96	3.09	0.13	1.48	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	32.31	3.77	2.12	0.71	1.89	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.21	3.37	2.78	0.20	1.19	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	26.19	1.87	4.44	0.47	1.87	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	39.19	2.49	2.28	0.21	1.24	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.56	3.10	1.77	0.44	0.88	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.48	1.88	2.51	0.21	1.88	0.63	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.74	1.62	0.67	0.13	2.02	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.46	2.72	2.21	0.00	1.02	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	26.41	1.93	2.89	0.58	0.96	0.77	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	33.53	2.41	1.20	0.00	1.38	0.34	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.95	2.47	2.19	0.27	1.37	0.55	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	18.39	3.45	2.46	0.16	1.31	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	26.42	1.70	2.22	0.17	1.02	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.71	4.59	2.37	0.15	0.89	0.59	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	28.25	2.93	1.87	0.00	0.80	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	24.33	1.52	1.38	0.28	1.38	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	26.67	3.10	2.14	0.24	1.90	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	21.77	5.44	2.82	0.40	1.41	0.60	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.30	3.30	3.39	0.09	1.32	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	15.37	2.45	7.69	0.00	1.40	1.05	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.34	3.02	3.93	0.00	0.30	0.60	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	31.70	4.28	8.81	0.12	0.12	1.47	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	12.37	5.68	7.13	1.16	0.73	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	5.48	10.95	3.65	1.22	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	31.35	4.52	8.74	0.00	0.90	1.21	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.83	5.88	8.14	0.68	0.90	2.49	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	14.98	11.98	17.67	1.20	0.00	2.40	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	27.51	5.43	10.27	0.35	0.00	1.53	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	16.86	7.26	19.42	0.85	1.07	1.92	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.62	11.42	10.82	0.60	0.60	0.60	1.80
Schwann Cells, donor1	11498-119F4	88.21	2.82	1.13	1.13	2.26	0.38	0.19
Schwann Cells, donor2	11578-120F3	17.01	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	48.20	1.31	0.22	0.44	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	26.84	2.19	4.38	0.55	2.19	1.10	0.55
Sebocyte, donor2	11301-117B5	30.79	1.38	2.76	0.92	0.92	0.46	0.00
Sebocyte, donor3	11378-118B1	50.29	3.71	4.74	0.82	0.82	0.21	0.21
Sertoli Cells, donor1	11255-116F4	38.10	1.66	1.66	8.28	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	36.72	5.65	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	32.82	3.52	1.76	2.38	0.88	0.35	0.00
Skeletal Muscle Cells, donor2	11358-117H8	49.88	2.89	2.17	3.61	1.45	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	56.01	5.02	2.51	0.00	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	40.37	1.26	1.73	0.47	1.26	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	37.76	1.19	1.64	0.00	2.08	0.30	0.45
Skeletal Muscle Cells, donor6	11459-119B1	39.09	2.00	1.54	0.62	1.08	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	32.26	8.32	4.28	1.64	1.51	1.51	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.10	5.99	2.57	1.28	1.57	0.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.99	1.69	1.29	0.50	0.99	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.35	3.20	1.77	3.03	0.84	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	98.43	4.34	2.17	3.62	2.90	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	99.90	7.29	7.98	1.65	1.93	0.55	0.28
Skin - palm, donor1	10286-104F7	21.49	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	26.38	3.75	6.34	2.02	0.72	1.15	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	2.45	2.45	8.18	1.64	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.17	2.73	7.40	1.82	1.56	1.69	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	18.63	5.00	5.28	2.64	0.97	0.56	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	29.96	4.36	4.22	3.66	0.84	0.56	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	50.32	5.29	1.06	12.05	1.06	1.06	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	30.58	5.77	6.90	3.07	1.27	0.75	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	62.33	9.26	3.70	3.09	1.23	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.45	4.22	0.67	2.67	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	68.19	4.70	5.29	2.35	3.53	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.29	1.77	1.77	1.10	1.10	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	55.13	3.15	1.97	1.18	2.36	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	86.53	6.95	4.64	3.09	3.09	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	4.00	2.00	3.00	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.31	5.72	1.20	1.20	0.93	0.67	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	48.54	4.88	3.99	4.21	1.55	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	72.34	7.94	5.12	1.15	1.15	0.64	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	40.05	4.56	0.33	2.93	0.65	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	53.75	2.95	0.59	0.59	1.18	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	39.15	3.70	1.42	0.85	1.14	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	61.17	6.02	2.60	1.30	1.95	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.66	5.48	2.44	4.87	1.22	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	47.48	1.77	1.52	0.76	1.26	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	65.80	3.34	2.38	1.43	2.38	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	42.91	3.39	3.83	1.47	2.06	0.15	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	36.16	1.94	2.15	0.43	1.94	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	40.20	3.78	2.31	0.63	1.47	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	45.17	3.87	1.55	1.08	1.39	0.62	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	54.97	7.55	5.39	2.16	2.16	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	56.48	2.39	0.90	0.90	2.39	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	58.38	2.73	3.41	1.02	2.05	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.52	4.48	1.65	1.33	0.47	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.93	8.35	1.51	3.52	1.21	0.60	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	34.36	2.28	2.05	1.82	1.37	1.14	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	80.91	6.04	5.43	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.08	2.12	1.85	0.79	0.26	0.53	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	37.55	3.99	3.99	1.07	0.80	0.67	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	38.94	5.26	4.38	3.51	2.00	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	46.67	4.57	2.54	0.00	0.51	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	38.15	3.32	1.81	1.51	1.51	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	60.01	1.50	4.50	0.75	2.25	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	33.60	0.00	0.00	0.00	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	46.97	5.58	0.47	2.79	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	59.58	11.11	3.03	1.51	2.02	1.51	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	49.52	5.01	2.51	1.57	2.51	0.94	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	38.35	5.01	2.06	1.77	0.88	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	39.82	2.00	1.75	0.58	1.08	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	47.65	3.74	0.47	1.87	1.87	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	39.15	7.20	1.87	3.02	2.16	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	57.11	4.59	2.29	2.29	1.27	1.02	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	72.77	3.76	1.13	1.50	1.69	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	53.10	2.93	0.56	1.12	0.70	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	69.80	4.86	1.01	2.26	0.84	0.34	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	34.29	9.05	1.43	1.90	1.43	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	44.77	4.89	1.71	2.94	1.47	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	48.39	5.97	1.99	0.88	1.10	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	40.08	2.05	2.05	0.29	1.17	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.47	7.19	2.53	1.36	0.39	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.28	4.23	0.26	0.79	0.79	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.90	5.21	3.35	1.86	0.00	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	13.65	11.14	11.50	3.23	0.36	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	20.44	3.41	1.14	1.70	2.27	0.57	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.30	4.33	5.12	1.58	1.18	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	9.90	3.56	2.29	1.78	1.27	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	10.38	13.58	6.39	1.60	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	4.18	1.25	0.42	0.84	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	15.13	3.67	2.29	1.38	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	14.14	5.22	1.85	1.85	0.00	1.01	0.50
Synoviocyte, donor2	11368-117I9	37.88	3.02	7.54	2.85	0.84	0.67	0.00
Synoviocyte, donor3	11440-118H9	40.66	4.02	9.16	1.79	0.45	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	26.80	4.65	3.57	0.36	1.79	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	39.64	1.98	17.84	3.96	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	34.04	3.94	3.24	0.69	1.16	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	22.72	2.72	1.22	1.15	1.72	0.29	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	39.82	1.16	0.77	0.39	2.32	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	40.09	1.15	2.29	1.15	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	22.02	2.46	2.21	0.62	0.12	0.49	0.37
Urethra, donor2	10319-105A4	19.78	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	46.23	5.84	2.13	1.06	3.45	0.53	0.53
Urothelial Cells, donor2	11600-120H7	33.25	2.80	1.60	1.20	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	44.47	4.58	2.06	1.60	1.38	0.00	0.23
Urothelial cells, donor0	11216-116B1	39.68	3.57	0.89	1.34	1.11	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	12.46	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	21.44	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	9.58	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	7.58	0.00	0.00	0.00	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	4.65	0.00	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	10.41	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	3.67	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	49.96	5.18	4.81	9.25	1.36	0.49	0.49
Wilms' tumor cell line:HFWT	10597-108E3	36.96	21.12	51.04	1.76	0.00	2.64	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	14.80	1.40	2.51	0.28	1.40	0.28	0.00
achilles tendon, donor2	10292-104G4	6.20	4.13	0.00	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	28.56	0.00	0.00	1.27	0.76	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	21.13	0.23	0.00	0.46	0.93	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	9.62	0.12	0.00	0.47	0.59	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	29.66	1.36	0.00	0.82	0.82	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	20.80	0.00	0.28	0.56	1.12	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	35.32	0.00	0.00	0.00	1.27	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.16	4.08	1.63	4.90	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	23.35	0.44	1.32	3.53	1.32	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	11.84	0.41	0.00	1.23	1.63	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	52.03	0.00	0.00	1.55	1.94	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	12.70	0.00	0.00	1.47	0.37	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	40.90	0.23	0.46	1.86	1.39	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	22.52	0.52	0.00	1.29	0.52	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.94	0.00	0.00	0.88	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	16.27	0.46	0.00	2.32	1.86	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.05	0.00	0.00	1.23	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.95	0.00	5.22	3.99	1.23	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.03	1.28	2.13	6.40	1.71	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	35.79	1.21	1.52	3.34	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	28.40	1.68	1.20	6.02	1.44	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.57	0.00	0.00	2.00	0.67	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	18.01	0.67	2.00	0.67	1.33	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	48.31	0.00	1.86	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	27.87	0.38	0.00	3.77	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	24.86	0.44	0.44	2.18	2.18	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	0.00	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	29.20	5.65	3.30	2.12	0.71	1.18	0.94
adipose tissue, adult, pool1	10010-101C1	12.41	0.78	0.47	0.00	0.31	0.16	0.16
adipose, donor1	10184-103D4	100.28	1.76	2.93	2.93	1.76	0.59	0.00
adipose, donor2	10185-103D5	85.16	21.49	14.60	10.14	2.03	3.65	0.41
adipose, donor3	10186-103D6	72.70	9.26	4.08	4.90	2.18	1.63	0.27
adipose, donor4	10187-103D7	25.14	3.47	6.93	0.87	1.73	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	18.46	3.16	0.00	0.16	0.16	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	36.38	3.64	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.07	0.40	0.00	0.67	0.27	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	35.37	1.43	5.36	1.79	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	45.67	2.55	0.70	1.85	0.70	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	100.42	0.68	2.37	1.01	1.01	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	43.31	1.77	0.29	2.65	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	28.46	3.56	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	53.94	4.26	0.61	0.81	0.20	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	10.33	4.52	3.23	0.65	0.65	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	19.10	10.31	0.76	5.22	0.38	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	60.01	0.00	0.00	2.43	1.76	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	63.13	6.01	1.00	2.00	2.00	0.00	0.33
aorta, adult, pool1	10052-101G7	29.42	2.35	0.78	0.39	0.00	0.20	0.00
appendix, adult	10189-103D9	18.24	3.88	1.16	2.72	0.78	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	30.61	2.06	0.00	3.44	0.34	0.00	0.00
artery, adult	10190-103E1	57.06	12.23	0.00	0.00	5.43	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	26.08	1.30	0.43	0.43	0.43	0.14	0.00
b cell line:RPMI1788	10427-106D4	17.25	3.87	0.15	1.49	0.30	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	58.54	4.72	1.11	0.83	0.28	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.46	0.20	0.10	0.79	0.40	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	11.05	3.51	2.18	1.84	0.33	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	18.45	0.00	1.12	3.36	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	12.17	1.30	0.11	0.22	0.22	0.11	0.11
blood, adult, pool1	10053-101G8	6.64	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.96	8.56	5.14	1.71	0.00	0.86	0.86
bone marrow, adult	10192-103E3	8.77	3.37	0.67	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	35.88	9.23	3.08	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	30.40	3.34	0.11	0.00	0.22	0.11	0.00
brain, fetal, pool1	10085-102B4	128.23	5.34	5.34	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	35.68	1.98	0.99	8.26	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	51.80	14.35	8.49	3.12	0.62	1.37	0.87
breast, adult, donor1	10080-102A8	17.05	1.26	0.63	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	16.01	0.76	0.13	0.25	0.38	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.69	3.71	3.40	0.62	1.86	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.71	2.99	0.46	0.23	0.92	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.70	3.15	6.54	3.39	0.24	1.21	0.73
carcinoid cell line:NCI-H1770	10703-109H1	37.61	4.70	0.47	0.94	3.29	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	21.33	2.63	1.86	3.28	0.66	0.33	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	27.89	0.63	0.63	0.32	0.95	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	41.79	24.22	32.21	5.86	0.80	2.40	2.13
caudate nucleus - adult, donor10196	10177-103C6	26.48	5.76	1.15	1.15	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	51.54	5.69	0.33	0.50	0.17	0.67	0.00
caudate nucleus, adult, donor10258	10379-105H1	39.74	3.82	0.00	1.53	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	9.52	10.62	6.23	0.37	0.73	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	26.22	32.05	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	39.29	20.92	0.21	0.85	0.21	0.64	0.00
cerebellum, adult, pool1	10083-102B2	30.01	16.56	2.41	0.34	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	9.96	7.47	3.32	0.00	0.00	1.66	0.83
cerebral meninges, adult	10188-103D8	40.09	2.52	0.00	0.00	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	32.89	3.65	0.73	0.73	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	46.01	6.76	15.38	2.30	0.86	1.44	2.59
cervical cancer cell line:ME-180	10553-107I4	40.27	0.83	0.00	1.99	1.33	0.00	0.00
cervix, adult, pool1	10013-101C4	20.79	1.15	0.10	1.15	0.42	0.00	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.44	4.18	2.51	0.70	0.84	0.98	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	1.31	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	55.05	0.99	1.24	2.49	1.12	0.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	64.07	1.72	1.11	8.87	0.37	0.37	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	108.63	5.69	4.27	2.37	0.95	1.42	0.95
chorionic membrane cells, donor1	12238-129G6	44.73	0.85	0.00	1.99	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	75.27	1.39	0.99	0.40	0.99	0.10	0.00
chorionic membrane cells, donor3	12240-129G8	25.28	1.65	0.00	2.20	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	0.00	0.00	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	43.22	0.96	0.77	1.15	0.77	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	56.81	0.42	4.01	3.17	1.90	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	20.29	1.80	6.16	0.26	0.00	1.54	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.98	2.18	5.08	2.18	0.00	1.45	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	13.64	1.63	6.52	1.22	0.20	1.22	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	46.52	0.00	2.36	2.36	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	21.37	0.00	0.26	1.04	0.78	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	32.00	4.11	0.46	0.46	1.14	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	17.18	0.35	0.35	0.69	0.35	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	21.05	0.18	0.37	1.46	0.55	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	36.87	0.38	0.38	1.14	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	34.51	4.76	2.38	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	28.20	1.18	1.29	1.29	0.71	0.59	0.12
colon, fetal, donor1	10070-101I7	20.39	13.60	32.14	4.33	0.62	0.62	2.47
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.75	2.55	2.97	7.22	1.27	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	22.04	2.87	1.81	2.11	1.66	0.91	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	24.25	2.26	1.69	2.26	1.27	0.00	1.41
corpus callosum, adult, pool1	10042-101F6	45.11	4.09	0.33	0.22	0.44	0.55	0.00
cruciate ligament, donor2	10295-104G7	2.43	0.81	3.24	0.81	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	73.03	24.08	8.03	1.61	0.00	10.43	2.41
diencephalon, adult	10193-103E4	47.28	4.56	0.24	0.00	0.48	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	23.88	0.00	0.00	1.61	1.15	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.33	0.77	0.26	2.05	1.03	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.39	3.85	5.54	6.98	0.24	0.00	0.48
ductus deferens, adult	10196-103E7	22.43	3.49	0.00	3.49	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	4.32	17.28	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.01	10.30	11.03	6.62	0.00	1.47	2.21
dura mater, adult, donor1	10041-101F5	16.35	0.74	0.58	1.24	0.25	0.17	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	29.09	1.33	0.22	4.89	1.11	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	28.80	1.00	0.43	2.01	0.86	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	29.60	4.32	0.00	0.62	3.08	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	21.80	4.84	1.21	0.91	0.61	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	29.64	5.25	3.09	3.09	1.85	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	49.91	2.63	1.31	2.63	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	16.42	2.68	0.34	7.37	0.34	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	31.17	13.23	4.53	1.09	1.09	0.72	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	40.36	3.06	0.16	2.89	0.48	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	13.78	1.11	1.33	1.00	0.33	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	17.38	0.33	0.33	0.22	0.44	0.00	0.00
epididymis, adult	10197-103E8	21.77	3.56	0.63	1.67	0.63	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	42.40	8.34	3.55	3.19	1.24	0.35	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	15.73	22.41	135.28	3.54	1.18	7.47	6.29
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	38.40	0.79	1.18	4.32	1.05	0.00	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	32.48	0.89	0.79	4.23	1.08	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	46.72	0.56	0.56	3.92	1.68	0.11	0.00
esophagus, adult, pool1	10015-101C6	21.34	0.74	0.42	0.53	0.21	0.21	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	20.91	3.76	3.26	10.77	0.13	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	24.15	16.90	12.07	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	35.77	2.10	0.00	2.10	6.31	2.10
eye - muscle medial, donor2	10299-104H2	46.13	49.11	4.46	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	20.64	28.66	9.17	1.15	0.00	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	4.37	1.46	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	34.32	6.86	0.00	0.76	0.76	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	37.57	0.64	1.41	1.80	0.64	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.01	3.09	1.19	0.24	0.00	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	30.21	7.51	0.38	0.19	0.28	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	30.33	0.00	0.00	2.10	1.20	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	15.64	3.38	0.37	0.73	0.46	0.18	0.00
gall bladder, adult	10198-103E9	23.18	1.21	0.72	1.21	0.72	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	14.50	0.00	0.00	0.00	1.07	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	16.06	0.37	0.00	0.75	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	28.73	1.27	1.48	6.55	0.84	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	70.98	0.19	0.00	4.06	1.35	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	47.71	3.93	0.49	1.80	2.13	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	10.98	0.92	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.41	1.83	2.06	3.43	0.23	0.91	0.00
giant cell carcinoma cell line:LU65	10487-107B1	5.51	0.34	0.23	0.57	0.23	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	35.13	11.20	18.75	2.52	1.54	1.40	2.10
glassy cell carcinoma cell line:HOKUG	10688-109F4	36.66	3.74	2.00	2.74	0.25	1.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	27.65	25.44	11.61	1.37	1.79	2.32	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	56.74	29.07	11.52	2.53	1.83	3.37	2.11
glioblastoma cell line:T98G	10485-107A8	16.56	6.29	2.87	0.77	0.11	0.33	0.33
glioma cell line:GI-1	10413-106B8	19.33	6.74	7.03	1.76	0.29	2.34	0.59
globus pallidus - adult, donor10196	10175-103C4	38.63	5.10	0.00	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	54.92	3.91	0.24	0.98	0.49	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	41.08	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.66	4.26	1.60	1.60	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	0.00	0.00	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	99.31	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.60	1.92	0.00	1.28	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	21.58	0.00	3.21	2.30	2.75	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	18.29	0.91	0.46	0.91	1.37	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	17.39	0.64	2.58	3.22	3.22	0.00	0.00
hIPS, biol_rep1	14380-156B6	4.31	2.87	2.87	4.31	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	2.06	0.00	2.74	2.06	0.00	0.00
hIPS, biol_rep3	14382-156B8	23.17	6.62	0.00	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	70.97	108.62	66.95	6.90	2.30	16.09	9.77
heart - mitral valve, adult	10205-103F7	19.13	4.78	0.60	0.60	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	27.72	17.00	1.05	1.57	1.31	1.05	0.52
heart - tricuspid valve, adult	10207-103F9	17.49	4.16	0.00	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	52.44	9.18	0.20	0.41	0.20	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	70.26	22.57	0.43	0.43	0.43	0.43	0.85
heart, adult, pool1	10016-101C7	97.97	27.83	1.84	1.15	1.38	3.22	0.23
heart, fetal, pool1	10046-101G1	53.09	50.11	2.67	1.33	0.51	2.67	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	32.40	7.71	0.93	1.54	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	0.00	3.57	9.51	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	61.77	3.65	4.86	5.41	0.88	0.55	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	69.55	3.03	2.55	4.98	0.49	0.49	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	65.18	4.04	3.33	5.36	0.61	0.20	0.40
hepatoma cell line:Li-7	10484-107A7	39.70	2.00	2.00	2.00	1.00	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.47	0.10	0.00	0.80	0.70	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	26.50	5.68	0.00	0.00	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	55.11	6.33	0.61	0.61	0.00	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	7.97	7.97	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	6.34	4.23	1.06	0.00	0.00	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	36.62	0.61	0.61	5.49	1.83	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.22	1.37	1.18	0.98	0.98	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	16.76	0.51	1.02	2.03	2.29	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	36.09	6.77	9.59	2.26	3.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	67.65	6.20	12.91	2.58	2.07	2.07	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.34	6.45	16.32	2.66	3.42	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	46.13	8.17	14.01	7.88	2.34	1.75	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	88.54	13.79	9.91	7.76	2.80	2.80	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	47.96	12.93	11.26	9.18	2.50	3.75	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	91.40	7.10	9.47	6.39	0.95	1.18	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	92.41	9.96	9.80	5.95	2.73	1.77	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	101.67	9.43	6.06	6.73	2.02	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.81	2.50	0.63	2.97	1.10	0.78	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	42.74	3.44	3.93	1.97	1.97	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	2.62	0.00	2.62	2.62	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	67.96	7.06	9.74	2.48	1.34	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.87	5.23	6.98	1.31	1.31	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	5.00	14.49	3.50	3.00	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	71.21	17.71	13.94	6.22	2.07	2.26	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	96.40	17.28	13.19	3.18	3.64	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.19	17.85	14.72	5.95	2.51	2.51	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	72.18	6.86	5.06	5.06	1.14	0.49	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	74.61	10.74	5.23	4.94	2.90	2.03	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	39.46	8.07	4.78	6.88	1.79	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.16	1.85	2.22	3.14	0.55	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	29.38	1.71	1.14	2.00	1.14	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	24.50	1.22	2.45	6.12	1.63	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	54.92	7.75	11.97	2.46	3.52	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	52.90	4.75	8.87	2.53	1.58	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.34	3.33	13.32	3.93	2.72	1.82	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	58.95	12.41	8.27	5.69	3.10	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	67.74	11.29	8.63	6.64	3.32	1.99	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.10	8.72	7.18	7.70	2.57	1.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	72.09	6.65	6.39	5.11	2.05	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	75.72	15.14	5.30	6.06	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.63	10.08	4.70	6.05	3.36	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.19	1.93	0.97	2.66	0.72	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	19.16	1.34	4.46	5.79	0.89	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	20.98	1.46	0.49	0.98	2.93	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	62.04	4.28	9.47	2.44	2.14	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	6.51	6.51	29.28	13.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	41.37	6.95	14.23	5.30	1.99	1.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	77.17	16.42	10.95	9.30	3.83	2.19	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.85	10.49	13.39	13.03	3.62	1.45	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	53.74	14.23	12.46	10.32	2.49	3.91	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	3.58	8.35	4.77	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	68.80	8.94	5.01	6.91	3.11	1.08	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	40.95	9.16	6.47	6.20	3.23	0.81	0.00
immature langerhans cells, donor1	11904-125F5	13.32	0.00	0.00	0.24	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	17.43	0.79	0.00	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	37.19	6.62	0.38	0.19	0.28	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	57.55	0.00	0.65	0.00	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	30.14	4.21	0.40	0.90	0.30	0.40	0.10
kidney, fetal, pool1	10045-101F9	31.19	1.70	0.28	0.64	0.21	0.14	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.56	0.85	0.14	5.54	0.57	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	35.80	6.77	3.18	3.46	1.80	0.14	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	43.31	5.32	0.73	0.92	2.20	0.00	0.00
left atrium, adult, donor1	10079-102A7	36.51	15.26	2.18	2.72	0.54	1.63	1.09
left ventricle, adult, donor1	10078-102A6	53.09	16.18	2.53	0.00	0.51	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	41.04	17.24	147.48	3.01	0.82	4.92	7.39
leiomyoma cell line:10964C	10569-108B2	55.32	6.83	2.87	4.31	1.44	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	29.89	3.26	1.63	1.09	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	35.94	10.68	5.58	1.46	1.70	1.21	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	114.29	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	3.14	0.00	2.09	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	37.66	0.24	0.24	2.95	0.47	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	32.65	9.22	7.50	1.72	0.47	1.09	0.78
liposarcoma cell line:SW 872	10726-110A6	48.25	5.97	2.44	1.83	0.61	0.49	0.24
liver, adult, pool1	10018-101C9	16.53	2.11	1.94	0.49	0.16	1.13	0.16
liver, fetal, pool1	10086-102B5	15.99	3.76	9.41	0.00	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	17.06	8.31	0.00	0.73	0.44	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	45.95	6.46	0.18	1.48	0.00	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	33.01	8.18	0.00	0.85	1.13	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	8.83	7.57	1.68	0.42	0.42	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	21.59	7.20	2.21	1.80	0.97	0.83	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	13.79	0.69	0.69	0.00	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	24.91	0.92	0.13	0.53	1.19	0.13	0.00
lung, adult, pool1	10019-101D1	17.48	0.47	0.24	0.35	0.12	0.00	0.00
lung, fetal, donor1	10068-101I5	21.69	2.57	0.29	1.14	0.29	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	16.50	0.92	0.00	0.00	0.46	0.46	0.00
lymph node, adult, donor1	10077-102A5	17.04	2.37	0.47	0.47	0.00	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	52.82	1.75	1.53	1.32	3.07	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	32.75	1.21	0.00	0.45	1.51	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	30.58	0.00	0.00	8.49	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	38.63	3.11	4.44	0.89	1.33	0.00	0.44
mature adipocyte, donor2	12232-129F9	26.15	3.32	1.66	0.21	0.42	0.62	0.42
mature adipocyte, donor3	12233-129G1	38.17	1.66	2.37	0.00	1.66	0.71	0.00
mature adipocyte, donor4	12234-129G2	32.64	2.90	15.27	0.53	0.53	1.05	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.97	1.43	0.48	4.29	0.48	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	34.97	7.90	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	35.31	5.70	0.00	0.55	0.55	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	30.82	6.67	0.64	0.64	0.32	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	14.07	3.84	1.71	0.85	0.43	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	25.48	5.91	0.34	0.68	0.51	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	41.17	6.79	0.00	1.91	0.21	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	3.85	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	21.54	6.82	2.51	0.36	0.36	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	27.91	3.89	0.00	0.00	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	41.49	5.88	0.00	1.24	0.15	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	27.92	7.84	0.24	0.41	0.16	0.57	0.08
medulla oblongata, newborn, donor10223	10361-105F1	9.03	13.89	0.69	0.69	1.39	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	17.05	1.77	1.11	3.99	0.66	0.66	0.00
medulloblastoma cell line:ONS-76	10759-110E3	35.58	7.83	10.39	0.61	1.71	1.59	1.10
melanoma cell line:COLO 679	10514-107E1	24.58	1.44	0.00	0.72	0.72	0.14	0.29
melanoma cell line:G-361	10465-106H6	22.26	0.81	1.09	1.90	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	11.04	0.00	0.36	1.09	0.54	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	35.25	0.00	0.00	1.76	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	51.07	0.00	0.00	0.78	1.30	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	53.70	3.68	1.23	1.23	0.46	0.15	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	31.27	4.00	1.27	0.55	0.36	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	38.51	2.07	3.31	1.24	1.66	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.79	1.69	1.83	0.70	2.25	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	63.74	4.43	1.16	0.00	0.96	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	9.72	3.47	2.78	2.08	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	51.15	2.57	1.03	1.37	1.72	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	42.79	1.27	1.50	0.35	0.58	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	47.35	2.25	0.80	0.13	1.72	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	34.71	3.65	1.49	0.27	0.95	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.98	1.14	0.57	0.14	0.71	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	11.86	1.65	1.65	0.33	0.66	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	53.97	2.08	0.28	0.69	0.83	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.09	3.84	0.35	0.70	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.81	3.47	0.41	0.82	0.82	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.57	3.95	0.72	1.44	1.44	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	48.52	3.83	0.72	0.31	0.21	0.10	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.01	1.37	0.23	0.68	0.68	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.95	1.68	0.42	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.17	2.09	0.15	0.90	0.75	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	47.88	2.28	0.61	0.70	0.61	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.62	1.47	0.37	0.00	1.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.18	3.15	0.29	0.29	0.57	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.47	7.16	19.37	0.00	1.68	2.95	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	55.71	5.48	7.31	1.37	1.37	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	38.62	4.86	7.67	1.53	1.53	1.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	40.05	5.50	6.54	0.79	1.05	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	33.89	8.32	6.47	0.62	1.54	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.48	4.71	3.77	1.41	1.18	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.86	3.05	6.43	1.69	2.37	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	33.40	3.93	8.25	1.57	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	31.97	3.71	9.73	1.85	3.71	0.46	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.01	5.19	7.50	2.60	1.15	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	39.04	5.58	3.57	3.12	1.78	1.56	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	35.33	6.49	7.21	0.72	1.92	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	35.20	1.47	8.07	0.73	0.73	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	31.55	5.03	4.70	1.01	0.67	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.84	5.32	9.01	1.64	1.23	0.41	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	30.93	3.87	6.01	1.72	0.86	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	5.47	10.94	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	5.16	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.18	4.22	8.77	1.95	0.32	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	5.82	4.36	1.45	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	31.45	5.33	7.46	1.07	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	35.16	2.45	8.18	0.82	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	25.27	4.28	5.05	1.17	1.55	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	4.20	4.20	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	2.98	2.98	1.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	19.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.06	2.96	5.93	0.59	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	4.87	7.31	0.00	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	22.80	3.17	10.13	0.63	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.83	4.48	5.17	0.34	1.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	4.30	2.15	6.45	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	7.98	3.99	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	3.44	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	27.71	6.11	8.96	2.85	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	25.42	2.38	7.15	1.59	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.22	10.02	2.95	1.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.94	6.23	2.81	0.94	1.56	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	8.02	5.35	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	44.94	2.37	1.18	0.00	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	2.57	2.57	2.57	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	45.43	4.13	0.69	1.38	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	59.38	3.96	0.49	0.00	1.48	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	42.62	7.85	0.00	1.12	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	47.70	3.18	2.54	1.27	1.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	72.13	2.82	0.40	0.40	3.22	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	65.42	4.36	2.18	0.00	6.54	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	46.88	2.53	0.00	0.00	3.80	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	39.45	0.61	0.61	2.43	0.61	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	0.00	0.00	13.56	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	43.66	2.47	1.65	0.00	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	42.46	5.56	1.79	0.60	1.19	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	45.43	5.52	1.95	2.92	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	44.82	2.04	2.04	2.04	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	73.50	8.51	6.96	1.55	1.55	2.32	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	26.70	43.00	14.65	1.42	1.42	5.91	2.83
mesothelioma cell line:ACC-MESO-4	10494-107B8	56.99	7.65	10.43	4.40	1.16	1.85	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	8.55	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	100.90	7.19	9.04	6.58	1.23	0.92	0.62
mesothelioma cell line:Mero-25	10850-111F4	17.48	1.82	2.04	13.39	1.59	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	13.94	0.73	2.69	0.98	0.49	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	13.73	3.32	1.33	0.89	1.33	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	18.92	1.84	1.58	6.83	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	13.79	8.85	3.23	2.38	0.51	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	19.97	2.53	2.78	0.76	0.25	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	14.70	5.38	2.07	1.45	0.62	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	26.50	2.32	2.15	0.83	0.99	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	17.74	0.72	1.81	2.90	0.90	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	15.20	11.96	19.82	3.42	1.02	2.56	1.54
mesothelioma cell line:NCI-H28	10845-111E8	24.43	26.46	35.37	4.07	1.27	9.67	2.04
mesothelioma cell line:No36	10857-111G2	13.70	1.30	5.55	1.63	1.30	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	11.65	2.71	1.90	1.63	0.00	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	18.23	1.15	0.19	0.77	0.19	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	17.95	0.73	0.73	0.37	0.49	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	27.28	0.36	0.54	0.36	0.72	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	28.73	4.90	2.94	1.31	0.98	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	30.94	2.12	0.21	0.00	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.28	0.00	0.00	0.46	0.46	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	58.04	1.52	0.76	0.38	2.09	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	27.35	0.74	0.00	0.92	0.92	0.00	0.00
myeloma cell line:PCM6	10474-106I6	20.16	1.58	1.38	0.40	0.59	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	45.15	1.01	0.00	0.51	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	24.71	2.16	0.78	0.00	0.59	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	42.12	4.79	1.56	1.45	1.23	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.03	4.63	2.21	2.50	1.10	0.29	0.29
nasal epithelial cells, donor2	12227-129F4	32.02	9.94	2.21	0.55	0.55	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	43.94	0.46	0.23	3.68	0.92	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	35.17	3.18	0.56	0.56	1.68	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	39.86	6.54	0.21	2.95	2.53	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	72.12	0.37	0.19	2.05	0.93	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.47	0.24	0.00	0.24	0.71	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	42.45	1.11	0.48	4.28	0.95	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	41.86	0.00	0.00	0.60	0.81	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	35.60	0.00	0.00	1.27	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	32.74	3.73	1.06	1.86	1.86	0.80	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	12.85	1.01	0.34	0.34	0.68	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	129.68	20.01	5.60	1.60	3.20	3.20	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	61.56	13.14	5.13	10.58	1.92	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	43.09	4.47	6.83	2.89	1.05	1.31	0.53
nucleus accumbens, adult, pool1	10037-101F1	39.09	6.75	0.28	0.37	0.75	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	18.54	6.18	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	40.25	5.90	0.27	1.07	0.00	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	14.19	4.73	0.73	0.36	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	38.57	5.51	0.79	0.52	0.52	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	81.96	15.45	4.72	1.29	1.72	0.00	0.43
occipital pole, adult, pool1	10036-101E9	34.93	5.05	0.16	0.32	0.32	0.08	0.00
olfactory region, adult	10195-103E6	37.06	5.16	0.19	0.38	0.76	0.19	0.19
optic nerve, donor1	10277-104E7	40.02	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	13.44	0.57	0.68	1.37	1.48	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.90	0.27	0.27	0.41	0.55	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.17	0.51	0.17	1.69	0.85	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.87	0.12	0.00	1.16	0.23	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	27.34	4.12	3.53	1.18	1.47	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.96	0.93	0.00	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	20.78	2.54	2.33	7.63	0.85	0.00	0.21
ovary, adult, pool1	10020-101D2	18.78	1.22	0.09	0.17	0.52	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	15.40	5.87	1.65	0.73	0.55	0.73	0.00
pancreas, adult, donor1	10049-101G4	67.73	8.47	3.76	3.76	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	69.05	3.07	8.67	7.83	1.12	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	28.96	1.87	0.34	2.38	0.85	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	23.35	0.99	0.83	1.32	0.66	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	30.75	6.22	0.09	0.27	0.37	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	17.62	3.67	0.73	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	31.98	4.70	0.94	0.00	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	33.92	7.70	0.29	0.00	0.29	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	38.60	5.38	0.09	0.09	0.26	0.18	0.00
parietal lobe, fetal, donor1	10072-101I9	64.98	6.79	1.94	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	10.84	8.22	2.24	0.75	1.12	0.75	0.00
parotid gland, adult	10199-103F1	41.93	6.17	0.62	1.23	0.62	0.62	0.00
penis, adult	10200-103F2	22.02	1.07	1.07	0.00	0.00	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	16.73	2.42	0.19	1.67	1.12	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.85	1.31	0.15	0.73	0.73	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	24.51	0.65	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	24.28	3.55	0.00	1.18	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	20.07	3.76	0.63	0.63	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	32.38	16.19	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	55.25	20.33	0.52	1.56	0.52	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	39.16	24.69	0.00	1.70	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	22.04	0.65	0.54	1.51	0.43	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	19.86	0.26	0.00	0.93	0.66	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.93	9.96	8.87	0.62	0.78	1.71	0.31
pons, adult, pool1	10033-101E6	23.15	14.46	0.34	0.09	0.34	0.34	0.26
postcentral gyrus, adult, pool1	10032-101E5	39.66	5.23	0.35	0.52	0.09	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	0.00	0.00	6.27	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	93.64	0.00	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	28.55	6.26	2.77	1.60	1.02	0.73	0.58
prostate cancer cell line:PC-3	10439-106E7	23.41	7.26	2.00	0.18	1.27	0.54	0.18
prostate, adult, pool1	10022-101D4	27.48	2.54	0.18	0.36	0.36	0.09	0.09
putamen, adult, donor10196	10176-103C5	52.17	7.55	0.47	0.00	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	60.78	5.88	0.00	3.92	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	2.19	0.00	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	25.37	2.90	0.48	0.00	0.48	0.00	0.00
putamen, newborn, donor10223	10365-105F5	6.75	7.50	4.50	0.00	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	10.76	0.29	0.29	1.75	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	33.38	1.39	6.95	9.74	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.87	30.53	28.62	2.54	0.64	5.30	4.24
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	39.35	240.24	85.74	3.73	0.83	24.85	11.60
retina, adult, pool1	10030-101E3	30.91	3.58	0.30	0.50	0.40	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	43.65	2.86	3.64	5.20	1.56	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	32.46	1.48	1.60	3.44	0.86	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.59	1.41	0.84	0.28	0.56	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	33.35	1.52	2.27	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	15.38	4.05	8.90	1.29	0.97	0.65	0.00
salivary acinar cells, donor2	11772-123I8	34.83	3.86	9.36	2.20	0.96	0.41	0.00
salivary acinar cells, donor3	11773-123I9	40.39	0.66	3.97	3.97	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	57.20	10.30	0.57	0.57	1.14	1.72	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.11	3.71	2.19	0.84	0.59	0.25	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	18.57	3.64	3.17	0.94	0.12	0.59	0.24
seminal vesicle, adult	10201-103F3	22.22	1.06	0.00	3.17	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	28.91	2.92	1.21	5.83	0.73	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.32	0.50	0.00	0.00	0.75	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	1.00	1.00	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.94	2.69	1.61	5.64	0.13	0.27	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	10.17	2.10	1.22	1.44	1.22	0.88	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	34.84	4.13	7.23	1.55	1.42	0.52	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	42.56	3.55	2.13	0.00	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	60.09	6.00	0.84	0.48	2.16	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	42.21	0.00	1.01	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	37.87	6.31	2.52	2.52	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	62.04	0.00	0.33	1.00	1.67	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	31.84	0.63	0.00	2.84	0.95	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	38.74	4.43	0.39	0.00	1.93	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	26.70	0.00	0.00	2.31	1.81	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	27.51	0.80	0.32	0.32	1.13	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	58.84	12.86	4.14	3.27	1.53	1.53	0.87
small intestine, adult, pool1	10024-101D6	26.99	4.78	3.34	0.96	0.96	1.19	0.36
small intestine, fetal, donor1	10064-101I1	41.77	22.85	79.11	15.72	0.00	6.39	5.16
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.24	0.00	1.03	1.03	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	24.81	1.03	0.00	0.00	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	17.15	2.41	0.00	1.07	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	20.65	4.36	0.23	0.69	0.46	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	33.12	5.91	0.79	0.79	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	16.60	5.53	0.00	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	66.47	10.37	0.00	0.00	1.83	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	12.86	1.84	0.00	0.46	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	33.01	5.23	3.14	2.24	0.75	0.30	0.15
spleen, adult, pool1	10025-101D7	15.97	0.55	0.55	1.10	0.44	0.11	0.00
spleen, fetal, pool1	10044-101F8	16.84	1.35	1.03	0.79	0.64	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.08	3.21	3.11	1.04	0.52	1.14	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	19.75	0.38	0.38	1.14	1.14	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	29.00	2.45	0.35	0.35	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	38.31	1.17	0.00	2.74	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.33	1.91	0.11	0.90	0.34	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	0.42	0.42	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.04	2.12	0.85	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	37.38	0.00	0.00	2.14	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	24.50	5.13	1.14	0.57	0.00	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	58.99	6.02	0.00	0.42	0.00	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	12.93	6.21	1.03	0.00	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	6.36	4.24	1.41	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	33.93	3.21	0.00	1.60	1.15	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	47.73	7.21	0.59	0.42	0.25	0.25	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	89.75	5.70	1.42	0.00	0.71	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	45.71	8.35	0.88	0.44	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	65.63	7.68	11.17	3.84	2.09	0.70	1.05
tenocyte, donor2	11765-123I1	51.88	5.34	4.20	0.76	1.14	1.14	0.38
tenocyte, donor3	11768-123I4	56.71	5.56	8.15	1.85	0.00	1.48	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	20.06	1.19	5.78	1.36	0.00	0.85	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	104.20	14.64	21.43	10.17	1.23	2.00	1.08
teratocarcinoma cell line:PA-1	10807-111A6	60.75	4.96	4.49	0.93	0.77	0.62	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	45.07	0.63	2.79	2.29	1.52	0.38	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	26.47	0.76	4.92	2.65	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	47.33	0.44	2.29	1.31	0.44	0.33	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	25.73	0.65	0.00	3.91	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	35.86	7.95	1.61	1.93	2.25	0.86	0.00
testis, adult, pool2	10096-102C6	27.97	13.53	2.26	2.26	1.35	0.90	0.00
thalamus - adult, donor10196	10168-103B6	26.50	9.94	0.00	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	42.82	3.91	0.00	0.78	0.00	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	29.25	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.43	11.03	0.49	0.16	0.16	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	3.45	8.63	1.15	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	29.46	8.49	0.75	0.75	1.00	1.00	0.75
throat, fetal, donor1	10061-101H7	48.75	4.27	1.22	1.22	1.22	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	27.23	1.39	0.00	1.39	0.99	0.00	0.00
thymus, adult, pool1	10027-101D9	13.92	0.50	0.10	0.30	0.10	0.20	0.00
thymus, fetal, pool1	10043-101F7	17.98	1.56	0.42	0.21	0.21	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.00	2.53	2.93	1.20	1.60	0.40	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	41.63	6.29	3.63	3.77	1.54	0.42	0.28
thyroid, adult, pool1	10028-101E1	39.94	2.52	0.09	0.75	0.75	0.28	0.00
thyroid, fetal, donor1	10060-101H6	46.93	9.76	2.37	3.16	1.05	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	3.08	0.00	0.00	0.00	3.08	3.08
tongue, adult	10203-103F5	29.54	11.16	1.40	0.23	0.93	1.63	0.23
tongue, fetal, donor1	10059-101H5	90.64	19.70	2.76	0.00	0.79	1.58	1.18
tonsil, adult, pool1	10047-101G2	21.54	3.21	1.70	0.20	0.60	0.70	0.00
trachea, adult, pool1	10029-101E2	19.06	0.65	0.16	0.57	0.57	0.08	0.08
trachea, fetal, donor1	10058-101H4	41.93	6.54	1.15	1.54	0.38	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.28	4.61	6.02	2.13	1.06	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	29.79	1.22	1.82	0.71	1.72	0.71	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	22.88	25.54	31.18	8.15	0.78	4.39	3.29
tridermal teratoma cell line:HGRT	10694-109G1	36.15	0.00	1.90	3.81	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.91	0.93	0.59	2.03	0.25	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	41.73	2.09	4.17	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	20.65	0.68	0.17	0.34	0.17	0.17	0.00
uterus, fetal, donor1	10055-101H1	50.17	3.58	1.02	0.51	0.00	0.00	0.00
vagina, adult	10204-103F6	6.46	0.00	0.00	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	11.18	2.19	1.10	1.10	0.00	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	39.52	0.00	0.00	0.00	0.53	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "LF346345:224 MA581922:224 LF346346:-286 MA581923:-286 AF393504:-355 CR533481:-355 AB528207:-356 AM393672:-356 KJ898712:-356 ENST00000497413.1:-360 ENST00000462205.5:-361 AF164795:-363 AL136644:-376 BC024648:-376 AF161490:-376 ENST00000247665.12:-377 NM_014172.6:-377 NM_001135861.3:-377 NM_001287343.2:-377 NM_001287342.2:-377 NR_109808.2:-377 NR_109807.2:-377" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.